SCHEMBL6094631

SCHEMBL6094631

CCC(CO)NC(=O)/C=C/c1cc(O)ccc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ AURKA O14965 1/20 0.44
▸ AURKB Q96GD4 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ TAS1R3 Q7RTX0 2/20 0.42
▸ TAS1R1 Q7RTX1 2/20 0.42
▸ PELI1 Q96FA3 2/20 0.40
▸ SNCA P37840 1/20 0.40
▸ BACE1 P56817 5/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6094635 1.00 HPGD (0.48) HPGDLMNASMN1; SMN2AURKAAURKB
SCHEMBL6095980 0.92 AURKA (0.45) HPGDLMNASMN1; SMN2AURKAAURKB
SCHEMBL6095986 0.92 AURKA (0.45) HPGDLMNASMN1; SMN2AURKAAURKB
SCHEMBL6139193 0.89 LMNA (0.49) HPGDLMNASMN1; SMN2AURKAAURKB
SCHEMBL6139201 0.89 LMNA (0.49) HPGDLMNASMN1; SMN2AURKAAURKB
Hydrochloric Acid SCHEMBL6138893 0.88 LMNA (0.48) HPGDLMNASMN1; SMN2AURKAAURKB
Hydrochloric Acid SCHEMBL6138897 0.88 LMNA (0.48) HPGDLMNASMN1; SMN2AURKAAURKB
SCHEMBL6096687 0.85 SNCA (0.42) HPGDAURKAAURKBTAS1R3TAS1R1
SCHEMBL6096691 0.85 SNCA (0.42) HPGDAURKAAURKBTAS1R3TAS1R1
SCHEMBL6096811 0.81 SNCA (0.41) HPGDAURKAAURKBPELI1SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7070626-B2 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds WELLA AG (DE) 2006-07-04 — — US disclosed
EP-1286953-B1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS WELLA AG (DE) 2004-02-18 — — EP disclosed
US-20030192132-A1 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2003-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030192132-A1 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds KRT18, ALDH7A1, IK HPGD 45/4885LMNA 464/4885SMN1; SMN2 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback